GluN2C/D Subunit Selective Antagonists of the N-Methyl-D-Aspartate Receptor
US-2024294493-A1 · Sep 5, 2024 · US
Substituted 1,3-thiazoles as heat shock transcription factor 1 activators
US9447058B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9447058-B2 |
| Application number | US-201514878749-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 8, 2015 |
| Priority date | Nov 12, 2010 |
| Publication date | Sep 20, 2016 |
| Grant date | Sep 20, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to 1,3-thiazole compounds, methods for their discovery, and their research and therapeutic uses, as well as pharmaceutically acceptable salts, solvates, chelates, non-covalent complexes, prodrugs, mixtures (including both R and S enantiomeric forms and racemic mixtures thereof), and pharmaceutical Formulations thereof.
First claim
Opening claim text (preview).
We claim: 1. A compound selected from the group consisting of:
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Drugs for disorders of the cardiovascular system · CPC title
Anti-Parkinson drugs · CPC title
for treating abnormal movements, e.g. chorea, dyskinesia · CPC title
Ophthalmic agents · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9447058B2 cover?
- The present invention relates to 1,3-thiazole compounds, methods for their discovery, and their research and therapeutic uses, as well as pharmaceutically acceptable salts, solvates, chelates, non-covalent complexes, prodrugs, mixtures (including both R and S enantiomeric forms and racemic mixtures thereof), and pharmaceutical Formulations thereof.
- Who is the assignee on this patent?
- Univ Duke, Chaperone Therapeutics Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/4155. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).